BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29947313)

  • 1. Significant concordance of genetic variation that increases both the risk for obsessive-compulsive disorder and the volumes of the nucleus accumbens and putamen.
    Hibar DP; Cheung JW; Medland SE; Mufford MS; Jahanshad N; Dalvie S; Ramesar R; Stewart E; van den Heuvel OA; Pauls DL; Knowles JA; Stein DJ; Thompson PM;
    Br J Psychiatry; 2018 Jul; 213(1):430-436. PubMed ID: 29947313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance of genetic variation that increases risk for anxiety disorders and posttraumatic stress disorders and that influences their underlying neurocircuitry.
    van der Merwe C; Jahanshad N; Cheung JW; Mufford M; Groenewold NA; Koen N; Ramesar R; Dalvie S; ; Knowles JA; Hibar DP; Nievergelt CM; Koenen KC; Liberzon I; Ressler KJ; Medland SE; Morey RA; Thompson PM; Stein DJ
    J Affect Disord; 2019 Feb; 245():885-896. PubMed ID: 30699873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shape analysis of subcortical structures in obsessive-compulsive disorder and the relationship with comorbid anxiety, depression, and medication use: A meta-analysis by the OCD Brain Imaging Consortium.
    Fouche JP; Groenewold NA; Sevenoaks T; Heany S; Lochner C; Alonso P; Batistuzzo MC; Cardoner N; Ching CRK; de Wit SJ; Gutman B; Hoexter MQ; Jahanshad N; Kim M; Kwon JS; Mataix-Cols D; Menchon JM; Miguel EC; Nakamae T; Phillips ML; Pujol J; Sakai Y; Yun JY; Soriano-Mas C; Thompson PM; Yamada K; Veltman DJ; van den Heuvel OA; Stein DJ
    Brain Behav; 2022 Oct; 12(10):e2755. PubMed ID: 36106505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder.
    Atmaca M; Onalan E; Yildirim H; Yuce H; Koc M; Korkmaz S; Mermi O
    J Anxiety Disord; 2011 Jun; 25(5):680-5. PubMed ID: 21441009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of genetic variation that increases risk for tourette syndrome and that influences its underlying neurocircuitry.
    Mufford M; Cheung J; Jahanshad N; van der Merwe C; Ding L; Groenewold N; Koen N; Chimusa ER; Dalvie S; Ramesar R; Knowles JA; Lochner C; Hibar DP; Paschou P; van den Heuvel OA; Medland SE; Scharf JM; Mathews CA; Thompson PM; Stein DJ;
    Transl Psychiatry; 2019 Mar; 9(1):120. PubMed ID: 30902966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic meta-analysis of obsessive-compulsive disorder and self-report compulsive symptoms.
    Smit DJA; Cath D; Zilhão NR; Ip HF; Denys D; den Braber A; de Geus EJC; Verweij KJH; Hottenga JJ; Boomsma DI
    Am J Med Genet B Neuropsychiatr Genet; 2020 Jun; 183(4):208-216. PubMed ID: 31891238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal striatal resting-state functional connectivity in adolescents with obsessive-compulsive disorder.
    Bernstein GA; Mueller BA; Schreiner MW; Campbell SM; Regan EK; Nelson PM; Houri AK; Lee SS; Zagoloff AD; Lim KO; Yacoub ES; Cullen KR
    Psychiatry Res Neuroimaging; 2016 Jan; 247():49-56. PubMed ID: 26674413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic alteration of subcortical nuclei shape in medication-free patients with obsessive-compulsive disorder.
    Zhang L; Hu X; Li H; Lu L; Li B; Hu X; Bu X; Tang S; Tang W; Liu N; Yang Y; Gong Q; Huang X
    Neuroimage Clin; 2019; 24():102040. PubMed ID: 31670068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.
    Wu K; Hanna GL; Easter P; Kennedy JL; Rosenberg DR; Arnold PD
    Psychiatry Res; 2013 Mar; 211(3):214-20. PubMed ID: 23154099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of nucleus accumbens volume in drug-naive, adult patients with obsessive-compulsive disorder.
    Narayanaswamy JC; Jose D; Kalmady S; Venkatasubramanian G; Reddy YC
    Aust N Z J Psychiatry; 2013 Oct; 47(10):930-7. PubMed ID: 23737599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered corticostriatal functional connectivity in obsessive-compulsive disorder.
    Harrison BJ; Soriano-Mas C; Pujol J; Ortiz H; López-Solà M; Hernández-Ribas R; Deus J; Alonso P; Yücel M; Pantelis C; Menchon JM; Cardoner N
    Arch Gen Psychiatry; 2009 Nov; 66(11):1189-200. PubMed ID: 19884607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional reward circuitry in obsessive-compulsive disorder.
    Figee M; Vink M; de Geus F; Vulink N; Veltman DJ; Westenberg H; Denys D
    Biol Psychiatry; 2011 May; 69(9):867-74. PubMed ID: 21272861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for inclusion of sex and age of onset variables in genetic association studies of obsessive-compulsive disorder: Overview.
    Mattina GF; Steiner M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jun; 67():107-16. PubMed ID: 26827635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
    Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcortical shape in pediatric and adult obsessive-compulsive disorder.
    Wang Z; Fontaine M; Cyr M; Rynn MA; Simpson HB; Marsh R; Pagliaccio D
    Depress Anxiety; 2022 Jun; 39(6):504-514. PubMed ID: 35485920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microstructural abnormality in left nucleus accumbens predicts dysfunctional beliefs in treatment-resistant obsessive-compulsive disorder.
    Li Z; Ji W; Li D; Li X; Feng W
    Med Sci Monit; 2014 Nov; 20():2275-82. PubMed ID: 25393961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain areas involved with obsessive-compulsive disorder present different DNA methylation modulation.
    de Oliveira KC; Camilo C; Gastaldi VD; Sant'Anna Feltrin A; Lisboa BCG; de Jesus Rodrigues de Paula V; Moretto AC; Lafer B; Hoexter MQ; Miguel EC; Maschietto M; ; Brentani H
    BMC Genom Data; 2021 Oct; 22(1):45. PubMed ID: 34717534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric investigation of the frontal-subcortical circuitry in patients with obsessive-compulsive disorder.
    Kang DH; Kim JJ; Choi JS; Kim YI; Kim CW; Youn T; Han MH; Chang KH; Kwon JS
    J Neuropsychiatry Clin Neurosci; 2004; 16(3):342-9. PubMed ID: 15377742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmentally stable whole-brain volume reductions and developmentally sensitive caudate and putamen volume alterations in those with attention-deficit/hyperactivity disorder and their unaffected siblings.
    Greven CU; Bralten J; Mennes M; O'Dwyer L; van Hulzen KJ; Rommelse N; Schweren LJ; Hoekstra PJ; Hartman CA; Heslenfeld D; Oosterlaan J; Faraone SV; Franke B; Zwiers MP; Arias-Vasquez A; Buitelaar JK
    JAMA Psychiatry; 2015 May; 72(5):490-9. PubMed ID: 25785435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.